Artificial Intelligence for Alzheimer’s Disease Detection: Enhancing Biomarker Analysis and Diagnostic Precision

Artificial Intelligence for Alzheimer’s Disease Detection: Enhancing Biomarker Analysis and Diagnostic Precision

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline and memory impairment. Early and accurate detection of AD is crucial for timely intervention and effective treatment. Biomarkers such as amyloid-beta and tau proteins, genetic markers like the APO...

Full description

Saved in:

Bibliographic Details
Main Authors:	Richa Gupta, Zoya Iftekhar
Format:	Article
Language:	English
Published:	MDPI AG 2024-11-01
Series:	Chemistry Proceedings
Subjects:	Alzheimer’s disease detection artificial intelligence biomarker analysis neurodegenerative disorders early diagnosis neuroimaging
Online Access:	https://www.mdpi.com/2673-4583/16/1/25
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The role of neuroimaging in Alzheimer’s disease: implications for the diagnosis, monitoring disease progression, and treatment
by: Julius Mulumba, et al.
Published: (2025-02-01)

Predicting Alzheimer's Disease onset: A machine learning framework for early diagnosis using biomarker data
by: Shehu Mohammed, et al.
Published: (2025-01-01)

Biomarker Investigation Using Multiple Brain Measures from MRI Through Explainable Artificial Intelligence in Alzheimer’s Disease Classification
by: Davide Coluzzi, et al.
Published: (2025-01-01)

Assessing the metabolism of the olfactory circuit by use of 18F-FDG PET-CT imaging in patients suspected of suffering from Alzheimer’s disease or frontotemporal dementia
by: Daniël S. L. Loewenstein, et al.
Published: (2024-10-01)

Case Report: The Alzheimer’s paradox: a clinically stable amnestic syndrome with full biomarker positivity and minimal imaging evidence
by: Anna-Chloé Balageas, et al.
Published: (2025-08-01)

Future of Alzheimer's detection: Advancing diagnostic accuracy through the integration of qEEG and artificial intelligence
by: Sahar Rezaei, et al.
Published: (2025-08-01)

Sex differences in the association of Alzheimer’s disease biomarkers and cognition in a multicenter memory clinic study
by: Cecilia Boccalini, et al.
Published: (2025-02-01)

APOE4 and chronic health risk factors are associated with sex-specific preclinical Alzheimer’s disease neuroimaging biomarkers
by: Genna M. Losinski, et al.
Published: (2025-05-01)

Association of critically short telomeres with brain and blood markers of ageing and Alzheimer’s disease in older adults
by: Asrar Lehodey, et al.
Published: (2024-12-01)

Rethinking the studies of diagnostic biomarkers for mental disorders
by: Jin Liu, et al.
Published: (2025-03-01)

Artificial intelligence in neuroimaging: Opportunities and ethical challenges
by: Neha Brahma, et al.
Published: (2024-01-01)

Argentina-Alzheimer's disease neuroimaging initiative (Arg-ADNI): neuropsychological evolution profile after one-year follow up
by: Patricio Chrem Méndez, et al.

Modern biomarkers as key tools in the early diagnosis and monitoring of Alzheimer's disease progression
by: Konrad Strużek, et al.
Published: (2025-04-01)

Advancements in the treatment of Alzheimer's disease: a comprehensive review
by: Srushti Rajanna, et al.
Published: (2025-04-01)

Neural correlates of subjective cognitive decline in Alzheimer’s disease: a systematic review of structural and functional brain changes for early diagnosis and intervention
by: Giulia Marafioti, et al.
Published: (2025-04-01)

Translational opportunities and barriers for blood-based biomarkers in Alzheimer’s disease: from discovery to implementation
by: WANG Yanjiang, et al.
Published: (2025-08-01)

Older US adults’ experiences with and views about cognitive screening and blood biomarker testing for Alzheimer's disease
by: Chelsea G. Cox, et al.
Published: (2025-01-01)

Biomarkers and Neuropsychological Tools in Attention-Deficit/Hyperactivity Disorder: From Subjectivity to Precision Diagnosis
by: Ion Andrei Hurjui, et al.
Published: (2025-07-01)

Proteomic landscape of Alzheimer’s disease: emerging technologies, advances and insights (2021 – 2025)
by: Jay M. Yarbro, et al.
Published: (2025-07-01)

Evaluating the safety and feasibility of remote ischemic conditioning for slowing cognitive decline in mild Alzheimer’s dementia
by: Xin Huang, et al.
Published: (2025-06-01)

Writing the Future: Artificial Intelligence, Handwriting, and Early Biomarkers for Parkinson’s Disease Diagnosis and Monitoring
by: Giuseppe Marano, et al.
Published: (2025-07-01)

Epigenetic Biomarkers Driven by Environmental Toxins Associated with Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the United States: A Systematic Review
by: Melanie Engstrom Newell, et al.
Published: (2025-01-01)

Advanced Magnetic Resonance Imaging for Early Diagnosis and Monitoring of Movement Disorders
by: Emmanuel Ortega-Robles, et al.
Published: (2025-01-01)

Longitudinal Analysis of Amyloid PET and Brain MRI for Predicting Conversion from Mild Cognitive Impairment to Alzheimer’s Disease: Findings from the ADNI Cohort
by: Do-Hoon Kim
Published: (2025-03-01)

Advancing Alzheimer’s Diagnosis: The Role of AI - A Review
by: Dominka Rehan, et al.
Published: (2025-01-01)

Frontotemporal dementia: a systematic review of artificial intelligence approaches in differential diagnosis
by: Serena Dattola, et al.
Published: (2025-04-01)

Use of Artificial Intelligence in Imaging Dementia
by: Manal Aljuhani, et al.
Published: (2024-11-01)

Optimizing timing and cost-effective use of plasma biomarkers in Alzheimer’s disease
by: Hsin-I Chang, et al.
Published: (2025-08-01)

Neuroprotective effect of ranolazine in mice's model of Alzheimer's disease
by: Mariam H. Sadiq, et al.
Published: (2024-06-01)

Editorial: Alzheimer’s disease
by: Ryszard Pluta
Published: (2025-06-01)

Non-Invasive Retinal Biomarkers for Early Diagnosis of Alzheimer’s Disease
by: Snježana Kaštelan, et al.
Published: (2025-01-01)

Dissection of blood–brain barrier dysfunction through CSF PDGFRβ and amyloid, tau, neuroinflammation, and synaptic CSF biomarkers in neurodegenerative disordersResearch in context
by: Agathe Vrillon, et al.
Published: (2025-05-01)

Preclinical development of an immunoassay for the detection of TREM2: a new biomarker for Alzheimer’s disease
by: Jie Hu, et al.
Published: (2025-07-01)

Cerebrospinal Fluid Biomarkers of Alzheimer Disease
by: Kseniya V. Nevzorova, et al.
Published: (2025-06-01)

Cerebrospinal fluid levels of tumour necrosis factor-α and its receptors are not associated with disease progression in Alzheimer’s disease
by: Manal Aljuhani
Published: (2025-04-01)

Recent advancements in the role of phytochemicals and Medicinal plants in prophylaxis and management of Alzheimer’s disease
by: Akanksha Mishra, et al.
Published: (2024-11-01)

Using cerebrospinal fluid biomarkers to diagnose Alzheimer’s disease: an Australian perspective
by: Dhamidhu Eratne, et al.
Published: (2024-12-01)

Multimodal attention fusion deep self-reconstruction presentation model for Alzheimer’s disease diagnosis and biomarker identification
by: Shan Huang, et al.
Published: (2025-12-01)

Machine learning based algorithms for virtual early detection and screening of neurodegenerative and neurocognitive disorders: a systematic-review
by: Milad Yousefi, et al.
Published: (2024-12-01)

A new method for community-based intelligent screening of early Alzheimer’s disease populations based on digital biomarkers of the writing process
by: Shuwu Li, et al.
Published: (2025-06-01)